Delivery Order SPE2DB20D9331-SPE2DB25FL1B8

Award Date 4/14/25
Potential Completion Date 5/5/25
Potential Value $164K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $80,218.40. The contract is for the delivery of KEYTRUDA 100 MG/4 ML VIAL 4ML, a pharmaceutical product, with a performance period ending on May 16, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $40,142.85 firm fixed-price contract is for the supply of Keytruda 100 mg/4 ml vial. The contract has an ultimate completion date of July 3, 2024. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $40,109.20, is a firm fixed-price delivery order for Keytruda 100 mg/4 ml vials. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, that runs through December 31,...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $90,245.65 for the supply of KEYTRUDA 100 MG/4 ML VIAL 4ML, a prescription medication. The contract has a firm fixed price and an ultimate completion date of June 4, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $47,651.39, is a delivery order for the supply of Keytruda 100 mg/4 ml vials. The contract has a firm fixed price and an ultimate completion date of May 13, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $98,274.72 firm fixed-price delivery order is for the supply of KEYTRUDA 100 MG/4 ML VIAL 4ML, a pharmaceutical product, with a period of performance through June 13, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,131.04 contract is to provide Keytruda 100 mg/4 ml vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is for the delivery of Keytruda 100 mg/4 ml vials. The ceiling value of the Firm Fixed Price delivery order is $96,262.08, with a performance period through May 13, 2024. The contract was awarded by the Defense Logistics Agency (DLA), Medical Supply Chain division, and is not set aside for any specific business type. DMS Pharmaceutical Group holds a significant $499,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,020.75 firm fixed-price delivery order contract is for the supply of KEYTRUDA 100 MG/4 ML VIAL 4ML, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2025 and was awarded on May 13, 2025. It is not associated with a set-aside designation. DMS Pharmaceutical Group...
This federal contract award, valued at $160,571.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of KEYTRUDA 100 MG/4 ML VIAL 4ML, with an ultimate completion date of August 12, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB25FL1B8
    Delivery Order

This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, for the supply of KEYTRUDA 100 MG/4 ML VIAL 4ML. The contract is a firm fixed-price arrangement with a ceiling value of $164,083.00 and a period of performance through May 5, 2025. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This contract award is not associated with any set-aside designation.

Generated 7/14/25, 11:04 AM